Current treatment options for elderly patients with multiple myeloma: clinical impact of novel agents

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.4, 2011-07, pp. : 415-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modern Treatment Options for Elderly Patients with Multiple Myeloma

Oncology Research and Treatment, Vol. 31, Iss. 6, 2008-05 ,pp. : 335-342

Karger

Access to resources Recommend Favorite

Extramedullary disease in multiple myeloma in the era of novel agents

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 6, 2015-06 ,pp. : 763-765

John Wiley & Sons Inc

Access to resources Recommend Favorite

A new staging system to predict prognosis of patients with multiple myeloma in an era of novel therapeutic agents

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 145-151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

Acta Haematologica, Vol. 132, Iss. 2, 2014-03 ,pp. : 211-219

Karger

Access to resources Recommend Favorite

The roles of consolidation and maintenance therapy with novel agents after autologous stem cell transplantation in patients with multiple myeloma

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 2, 2015-02 ,pp. : 109-114

John Wiley & Sons Inc

Access to resources Recommend Favorite